Safely and effectively promoting restoration of healthy tissue using novel cell-derived biotherapeutics.
At Noveome, our aim is to induce restoration of healthy tissue using ST266, a solution of biologically active components that is made by culturing our proprietary amnion-derived cells under novel conditions.Learn more »
Our products demonstrate the following unique attributes, which can be applied across a wide range of disease indications to improve patient outcomes.
Speeds Impaired Wound Healing
Restores Nerve Function
Strong Safety Profile
A newly published scientific study has demonstrated that damage to the optic nerve can be significantly reduced,Full Story
Noveome has named a veteran executive in pharmaceutical marketing and sales, Patrick Welch, to a new seat on its Board of DirectorsFull Story
Noveome has been awarded a significant grant from the Commonwealth of Pennsylvania to begin clinical trials for eye and brain diseases.Full Story